IFNG and myeloid sarcoma: In MS patients, TLR9 ligation is also a major trigger of pro-inflammatory B cells (48) and crucial for the differentiation of T-bet-expressing IgG1+ B cells during IFN-γ- and CD40-dependent GC-like cultures in vitro.